Urinary Urge Incontinence (UUI)

4

Review clinical trials related to Urinary Urge Incontinence (UUI). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).

Participants needed: 75
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Axonics, Inc.Updated: Jul 13, 2026Locations: 2
Eligibility criteria

18 years or older [+2]

Any participant that the study Investigator deems to be a poor candidate for any... [+3]

Status: Recruiting

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).

Participants needed: 75
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Axonics, Inc.Updated: Jun 15, 2026Locations: 2
Eligibility criteria

18 years or older [+2]

Any participant that the study Investigator deems to be a poor candidate for any... [+3]

Status: Recruiting

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.

Participants needed: 55
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Axonics, Inc.Updated: Jun 15, 2026Locations: 5
Eligibility criteria

18 years or older [+2]

Any significant medical condition that is likely to interfere with procedures, d... [+5]

Status: Recruiting

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

The APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with treatment and continued treatment efficacy in women with overactive bladder (OAB) randomized to a prescription digital therapeutic (PDTx) app called RiSolve compared to standard behavioral education (handouts).

Participants needed: 596
Trial details
Age: 22+Biological sex: FemaleType: InterventionalSponsor: Medstar Health Research InstituteUpdated: Oct 27, 2025Locations: 10
Eligibility criteria

Women ≥ 22 years old [+4]

Stress-predominant mixed urinary incontinence (defined as QUID stress score > QU... [+12]